NCT05003804: An ongoing trial by Siolta Therapeutics, Inc.
This trial is ongoing. It must report results 2 weeks, 5 days ago.
Full data
| Full entry on ClinicalTrials.gov | NCT05003804 |
|---|---|
| Title | A Phase 1b/2, Randomized, Double-blind, Placebo-controlled, Multi-center Study of STMC-103H in Neonates and Infants at Risk for Developing Allergic Disease |
| Results Status | Ongoing |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Sept. 1, 2021 |
| Completion date | Nov. 26, 2024 |
| Required reporting date | Nov. 26, 2025, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | Dec. 12, 2025 |
| Days late | None |